NCT05849662 2026-04-15
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT06466798 2026-01-08
Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
The University of Texas Health Science Center, Houston
Phase 1 Withdrawn
NCT06896110 2025-06-26
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
University of Iowa
Phase 1 Enrolling by invitation
NCT03206021 2024-04-05
COZMOS
The Hospital for Sick Children
Phase 1 Completed
NCT03666559 2024-02-29
AGIR
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT02940483 2018-11-30
5-AZA
The University of Texas Health Science Center, Houston
Phase EARLY_PHASE1 Completed